Literature DB >> 29964056

Atopic dermatitis in Chinese patients shows TH2/TH17 skewing with psoriasiform features.

Tom C Chan1, Riana D Sanyal2, Ana B Pavel2, Jacob Glickman2, Xiuzhong Zheng3, Hui Xu2, Yung-Tsu Cho4, Tsen-Feng Tsai4, Huei-Chi Wen2, Xiangyu Peng2, Inna Cueto3, James G Krueger3, Emma Guttman-Yassky5.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29964056     DOI： 10.1016/j.jaci.2018.06.016

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  14 in total

Review 1.  Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases.

Authors:  Hideyuki Ujiie; David Rosmarin; Michael P Schön; Sonja Ständer; Katharina Boch; Martin Metz; Marcus Maurer; Diamant Thaci; Enno Schmidt; Connor Cole; Kyle T Amber; Dario Didona; Michael Hertl; Andreas Recke; Hanna Graßhoff; Alexander Hackel; Anja Schumann; Gabriela Riemekasten; Katja Bieber; Gant Sprow; Joshua Dan; Detlef Zillikens; Tanya Sezin; Angela M Christiano; Kerstin Wolk; Robert Sabat; Khalaf Kridin; Victoria P Werth; Ralf J Ludwig
Journal:  Front Med (Lausanne)       Date:  2022-06-09

Review 2.  [Personalized medicine in the field of inflammatory skin diseases].

Authors:  N Garzorz-Stark; K Eyerich
Journal:  Hautarzt       Date:  2019-01       Impact factor: 0.751

3.  Antagonistic Effects of IL-4 on IL-17A-Mediated Enhancement of Epidermal Tight Junction Function.

Authors:  Matthew G Brewer; Takeshi Yoshida; Fiona I Kuo; Sade Fridy; Lisa A Beck; Anna De Benedetto
Journal:  Int J Mol Sci       Date:  2019-08-21       Impact factor: 5.923

4.  Particulate matter causes skin barrier dysfunction.

Authors:  Byung Eui Kim; Jihyun Kim; Elena Goleva; Evgeny Berdyshev; Jinyoung Lee; Kathryn A Vang; Un Ha Lee; SongYi Han; Susan Leung; Clifton F Hall; Na-Rae Kim; Irina Bronova; Eu Jin Lee; Hye-Ran Yang; Donald Ym Leung; Kangmo Ahn
Journal:  JCI Insight       Date:  2021-03-08

5.  RNA-Seq Identifies Marked Th17 Cell Activation and Altered CFTR Expression in Different Atopic Dermatitis Subtypes in Chinese Han Populations.

Authors:  Xin Tian; Baoyi Liu; Lijie Chen; Yongyi Xie; Jingyao Liang; Yan Yang; Lei Shao; Jing Zhang; Jianqin Wang; Xibao Zhang; Zhouwei Wu; Yumei Liu
Journal:  Front Immunol       Date:  2021-04-01       Impact factor: 7.561

Review 6.  HLA-Cw1 and Psoriasis.

Authors:  Yi-Wei Huang; Tsen-Fang Tsai
Journal:  Am J Clin Dermatol       Date:  2021-01-18       Impact factor: 7.403

Review 7.  Update on the Pathogenesis and Therapy of Atopic Dermatitis.

Authors:  Huaguo Li; Zhen Zhang; Hui Zhang; Yifeng Guo; Zhirong Yao
Journal:  Clin Rev Allergy Immunol       Date:  2021-08-02       Impact factor: 8.667

Review 8.  Immunological Aspects of Skin Aging in Atopic Dermatitis.

Authors:  Georgeta St Bocheva; Radomir M Slominski; Andrzej T Slominski
Journal:  Int J Mol Sci       Date:  2021-05-27       Impact factor: 5.923

Review 9.  Disease Mechanisms in Atopic Dermatitis: A Review of Aetiological Factors.

Authors:  Jacob P Thyssen; Maria Rasmussen Rinnov; Christian Vestergaard
Journal:  Acta Derm Venereol       Date:  2020-06-09       Impact factor: 3.875

10.  Exploration of biomarkers to predict clinical improvement of atopic dermatitis in patients treated with dupilumab: A study protocol.

Authors:  Takeshi Nakahara; Kenji Izuhara; Daisuke Onozuka; Satoshi Nunomura; Risa Tamagawa-Mineoka; Koji Masuda; Susumu Ichiyama; Hidehisa Saeki; Yudai Kabata; Riichiro Abe; Mamitaro Ohtsuki; Koji Kamiya; Tatsuro Okano; Tomomitsu Miyagaki; Yozo Ishiuji; Akihiko Asahina; Hiroshi Kawasaki; Keiji Tanese; Hiroshi Mitsui; Tatsuyoshi Kawamura; Takuya Takeichi; Masashi Akiyama; Emi Nishida; Akimichi Morita; Kyoko Tonomura; Yukinobu Nakagawa; Koji Sugawara; Chiharu Tateishi; Yoko Kataoka; Rai Fujimoto; Sakae Kaneko; Eishin Morita; Akio Tanaka; Michihiro Hide; Natsuko Aoki; Shigetoshi Sano; Haruna Matsuda-Hirose; Yutaka Hatano; Motoi Takenaka; Hiroyuki Murota; Norito Katoh; Masutaka Furue
Journal:  Medicine (Baltimore)       Date:  2020-09-18       Impact factor: 1.817
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.